{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:06:51Z","timestamp":1763136411383,"version":"3.45.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The clinical presentation of COVID-19 varies significantly by viral variant; the Delta variant often causes severe lung inflammation, whereas Omicron tends to result in less severe respiratory disease but may more readily affect other organs. The autoimmune mechanisms behind these variant-specific complications, particularly the potential role of anti-neutrophil cytoplasmic (ANCA) antibodies, are still not well defined. This study investigated myeloperoxidase (MPO), proteinase 3 (PR3), and glomerular basement membrane (GBM) antibodies in patients infected with the Delta and Omicron SARS-CoV-2 variants to evaluate their associations with specific clinical complications, such as renal or respiratory involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Samples were collected during Delta and Omicron outbreaks from hospitalized COVID-19 patients (40 Delta, 40 Omicron) and 40 healthy controls. Serum autoantibodies (MPO, PR3, GBM) were measured via ELISA, and laboratory\/clinical data were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All autoantibody levels remained within normal limits. Despite statistical significance (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05), effect sizes were small (\u03b7\u00b2=0.085\u20130.180). Anti-MPO was highest in the Delta group (1.08 U\/mL) vs. Control (0.71 U\/mL) and Omicron (0.77 U\/mL). Anti-PR3 was lowest in the Delta group (0.83 U\/mL) vs. Control (1.52 U\/mL). Anti-GBM was lowest in the Omicron group (1.48 U\/mL) vs. Control (3.48 U\/mL) and Delta (3.10 U\/mL).\n                    <\/jats:p>\n                    <jats:p>\n                      Clinically, the Delta group exhibited significantly lower oxygen saturation (92.28% \u00b1 8.69) than the Omicron group (96.15% \u00b1 2.77;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.009). Markers of inflammation and tissue damage\u2014including C-reactive protein (CRP), lactate dehydrogenase (LDH), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and coagulation parameters\u2014were markedly elevated in the Delta group compared to the Omicron group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Conversely, creatinine was significantly higher in the Omicron group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While autoantibody levels remained normal, clinical profiles diverged significantly between variants. The Delta variant was associated with heightened systemic inflammation, whereas Omicron was associated with greater organ involvement, suggesting the possibility of distinct pathogenic mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12865-025-00772-x","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:01:52Z","timestamp":1763136112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory tropism in COVID-19: a comparative analysis of Delta and Omicron variants"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1950-2241","authenticated-orcid":false,"given":"Afshin","family":"Samiei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Jandaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi Hassani","family":"Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Khayatian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4479-2938","authenticated-orcid":false,"given":"Narges","family":"Khaghanzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"8","key":"772_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00296-021-04914-3","volume":"41","author":"T Izci Duran","year":"2021","unstructured":"Izci Duran T, Turkmen E. ANCA-associated vasculitis after COVID-19. Rheumatol Int. 2021;41(8):1523\u20139.","journal-title":"Rheumatol Int"},{"issue":"6","key":"772_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218246","volume":"80","author":"S Su\u00e1rez-D\u00edaz","year":"2021","unstructured":"Su\u00e1rez-D\u00edaz S, Mor\u00e1n-Casta\u00f1o C, Coto-Hern\u00e1ndez R, Mozo-Avellaneda L, Su\u00e1rez-Cuervo C, Caminal-Montero L. Mild COVID-19 in ANCA-associated vasculitis treated with rituximab. Ann Rheum Dis. 2021;80(6):e99.","journal-title":"Ann Rheum Dis"},{"key":"772_CR3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-033092","author":"WT Powell","year":"2021","unstructured":"Powell WT, Campbell JA, Ross F, Pe\u00f1a Jim\u00e9nez P, Rudzinski ER, Dickerson JA. Acute ANCA vasculitis and asymptomatic COVID-19. Pediatrics. 2021. https:\/\/doi.org\/10.1542\/peds.2020-033092.","journal-title":"Pediatrics"},{"issue":"3","key":"772_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11239-020-02230-4","volume":"50","author":"S Deb","year":"2020","unstructured":"Deb S, Bandyopadhyay D, Shome G, Sarkar S, Paria SR, Thakurta TG, Singla P, Biswas SC, Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020;50(3):499\u2013511.","journal-title":"J Thromb Thrombolysis"},{"key":"772_CR5","doi-asserted-by":"publisher","unstructured":"Oliveira RMC, Santos DH. Bilateral trochlear nerve palsy due to cerebral vasculitis related to COVID-19 infection. Arq Neuropsiquiatr. 2020;78(6):385\u20136. https:\/\/doi.org\/10.1590\/0004-282X20200052","DOI":"10.1590\/0004-282X20200052"},{"issue":"10","key":"772_CR6","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1681\/ASN.2014090903","volume":"26","author":"M Hilhorst","year":"2015","unstructured":"Hilhorst M, van Paassen P, Tervaert JW. Proteinase 3-ANCA vasculitis versus Myeloperoxidase-ANCA vasculitis. J Am Soc Nephrology: JASN. 2015;26(10):2314\u201327.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"9","key":"772_CR7","doi-asserted-by":"publisher","first-page":"102618","DOI":"10.1016\/j.autrev.2020.102618","volume":"19","author":"S Moiseev","year":"2020","unstructured":"Moiseev S, Cohen Tervaert JW, Arimura Y, Bogdanos DP, Csernok E, Damoiseaux J, Ferrante M, Flores-Su\u00e1rez LF, Fritzler MJ, Invernizzi P, et al. : 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmun Rev. 2020;19(9):102618.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"772_CR8","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s11255-023-03490-8","volume":"55","author":"MSH Tan","year":"2023","unstructured":"Tan MSH, Choo JCJ, Tan PH, Kwek JL, Lim CC, Mok IY, et al. Anti-glomerular basement membrane glomerulonephritis following COVID-19 infection without clinically evident pneumonia. Int Urol Nephrol. 2023;55(7):1885\u20137.","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"772_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000517513","volume":"11","author":"F Maritati","year":"2021","unstructured":"Maritati F, Moretti MI, Nastasi V, Mazzucchelli R, Morroni M, Bagnarelli P, et al. Anca-associated glomerulonephritis and anti-phospholipid syndrome in a patient with SARS-CoV-2 infection: just a coincidence? Case Rep Nephrol Dial. 2021;11(2):214\u201320.","journal-title":"Case Rep Nephrol Dial"},{"issue":"Pt 5","key":"772_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1258\/000456307781646049","volume":"44","author":"D Sinclair","year":"2007","unstructured":"Sinclair D, Stevens JM. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides. Ann Clin Biochem. 2007;44(Pt 5):432\u201342.","journal-title":"Ann Clin Biochem"},{"key":"772_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.epsc.2021.102103","volume":"75","author":"T Wintler","year":"2021","unstructured":"Wintler T, Zherebtsov M, Carmack S, Muntean R, Hill SJ. Acute PR3-ANCA vasculitis in an asymptomatic COVID-19 teenager. J Pediatr Surg Case Rep. 2021;75:102103.","journal-title":"J Pediatr Surg Case Rep"},{"issue":"12","key":"772_CR12","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.ekir.2021.09.008","volume":"6","author":"N Klomjit","year":"2021","unstructured":"Klomjit N, Alexander MP, Fervenza FC, Zoghby Z, Garg A, Hogan MC, et al. COVID-19 vaccination and glomerulonephritis. Kidney Int Rep. 2021;6(12):2969\u201378.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"772_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103521","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Wang J, Liang S, Zhang Y, Feng Z, Cai G. Clinical phenotype of AAV, anti-GBM disease and double-positive patients after SARS-CoV-2 vaccination. Autoimmun Rev. 2024;23(4):103521.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"772_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.kint.2020.06.009","volume":"98","author":"M Prendecki","year":"2020","unstructured":"Prendecki M, Clarke C, Cairns T, Cook T, Roufosse C, Thomas D, et al. Anti\u2013glomerular basement membrane disease during the COVID-19 pandemic. Kidney Int. 2020;98(3):780\u20131.","journal-title":"Kidney Int"},{"issue":"7","key":"772_CR15","first-page":"474","volume":"122","author":"R Zahorec","year":"2021","unstructured":"Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474\u201388.","journal-title":"Bratisl Lek Listy"},{"key":"772_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1509289","volume":"15","author":"Y Galipeau","year":"2024","unstructured":"Galipeau Y, Cooper C, Langlois MA. Autoantibodies in COVID-19: implications for disease severity and clinical outcomes. Front Immunol. 2024;15:1509289.","journal-title":"Front Immunol"},{"issue":"12","key":"772_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102986","volume":"20","author":"A Kronbichler","year":"2021","unstructured":"Kronbichler A, Geetha D, Smith RM, Egan AC, Bajema IM, Sch\u00f6nermarck U, et al. The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum. Autoimmun Rev. 2021;20(12):102986.","journal-title":"Autoimmun Rev"},{"key":"772_CR18","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.ijn_423_21","author":"M Latief","year":"2023","unstructured":"Latief M, Mir TH, Wani ML. Management of antineutrophil cytoplasmic antibody\u2013associated vasculitis with COVID-19: a single center experience. Indian J Nephrol. 2023. https:\/\/doi.org\/10.4103\/ijn.ijn_423_21.","journal-title":"Indian J Nephrol"},{"issue":"2","key":"772_CR19","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/SLA.0000000000004004","volume":"272","author":"HMA Kaafarani","year":"2020","unstructured":"Kaafarani HMA, El Moheb M, Hwabejire JO, Naar L, Christensen MA, Breen K, Gaitanidis A, Alser O, Mashbari H, Bankhead-Kendall B, et al. Gastrointestinal complications in critically ill patients with COVID-19. Ann Surg. 2020;272(2):e61\u20132.","journal-title":"Ann Surg"},{"issue":"Suppl 2","key":"772_CR20","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.5152\/eurjrheum.2020.2067","volume":"7","author":"EJ Gapud","year":"2020","unstructured":"Gapud EJ, Kronbichler A, Gauckler P, Geetha D. Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic. Eur J Rheumatol. 2020;7(Suppl 2):S121-8.","journal-title":"Eur J Rheumatol"},{"issue":"8","key":"772_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102597","volume":"19","author":"M Ehrenfeld","year":"2020","unstructured":"Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597.","journal-title":"Autoimmun Rev"},{"key":"772_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2147\/IJNRD.S333894","volume":"14","author":"R Sebastian","year":"2021","unstructured":"Sebastian R, Arunachalam J, Rajendran M. Temporal clustering of antiglomerular basement membrane disease in COVID-19 pandemic: a case series. Int J Nephrol Renovasc Dis. 2021;14:393\u20138.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"772_CR23","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e204","author":"BC Kim","year":"2022","unstructured":"Kim BC, Kim HS, Han KH, Han SY, Jo HA. A case report of MPO-ANCA-associated vasculitis following heterologous mRNA1273 COVID-19 booster vaccination. J Korean Med Sci. 2022. https:\/\/doi.org\/10.3346\/jkms.2022.37.e204.","journal-title":"J Korean Med Sci"},{"key":"772_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15151905","author":"A Drynda","year":"2025","unstructured":"Drynda A, Surmiak M, Bazan-Socha S, Wawrzycka-Adamczyk K, Korkosz M, Musia\u0142 J, et al. Neutrophils and platelets as key players in the pathogenesis of ANCA-associated vasculitis and potential sources of disease activity biomarkers. Diagnostics. 2025. https:\/\/doi.org\/10.3390\/diagnostics15151905.","journal-title":"Diagnostics"},{"key":"772_CR25","unstructured":"Wada Y, Kuroda T, Nakano M, Narita I. Activated partial thromboplastin time reflects disease activity in patients with Anti-Neutrophil cytoplasmic Antibody-Associated vasculitis [abstract]. Arthritis Rheumatol. 2016;68.(Suppl 10). https:\/\/acrabstracts.org\/abstract\/activated-partial-thromboplastin-time-reflects-disease-activity-in-patients-with-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis\/"},{"issue":"1","key":"772_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09160-7","volume":"10","author":"J Perdomo","year":"2019","unstructured":"Perdomo J, Leung HHL, Ahmadi Z, Yan F, Chong JJH, Passam FH, et al. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat Commun. 2019;10(1):1322.","journal-title":"Nat Commun"},{"issue":"1","key":"772_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16915-8","volume":"12","author":"HM Esmaeel","year":"2022","unstructured":"Esmaeel HM, Ahmed HA, Elbadry MI, Khalaf AR, Mohammed NA, Mahmoud HA, et al. Coagulation parameters abnormalities and their relation to clinical outcomes in hospitalized and severe COVID-19 patients: prospective study. Sci Rep. 2022;12(1):13155.","journal-title":"Sci Rep"},{"issue":"3","key":"772_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.nefro.2020.07.013","volume":"41","author":"JA Fonseca","year":"2021","unstructured":"Fonseca JA, Gameiro J, Duarte I, Jorge S, Lopes JA. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in ANCA-associated vasculitis: a retrospective study. Nefrologia. 2021;41(3):321\u20138.","journal-title":"Nefrologia"},{"issue":"3","key":"772_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10238-020-00629-0","volume":"20","author":"L Huang","year":"2020","unstructured":"Huang L, Shen C, Zhong Y, Ooi JD, Zhou YO, Chen JB, et al. The association of neutrophil-to-lymphocyte ratio with all-cause mortality in Chinese patients with MPO-ANCA associated vasculitis. Clin Exp Med. 2020;20(3):401\u20138.","journal-title":"Clin Exp Med"},{"key":"772_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041128","author":"Y Mae","year":"2020","unstructured":"Mae Y, Takata T, Ida A, Ogawa M, Taniguchi S, Yamamoto M, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for renal outcomes in patients with rapidly progressive glomerulonephritis. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9041128.","journal-title":"J Clin Med"},{"issue":"5","key":"772_CR31","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.12669\/pjms.37.5.4194","volume":"37","author":"KU Toori","year":"2021","unstructured":"Toori KU, Qureshi MA, Chaudhry A, Safdar MF. Neutrophil to lymphocyte ratio (NLR) in COVID-19: a cheap prognostic marker in a resource constraint setting. Pak J Med Sci. 2021;37(5):1435\u20139.","journal-title":"Pak J Med Sci"},{"issue":"Supplement3","key":"772_CR32","doi-asserted-by":"publisher","first-page":"iii60","DOI":"10.1093\/rheumatology\/keaa035","volume":"59","author":"I Neumann","year":"2020","unstructured":"Neumann I. Immunosuppressive and glucocorticoid therapy for the treatment of ANCA-asssociated vasculitis. Rheumatology. 2020;59(Supplement3):iii60\u20137.","journal-title":"Rheumatology"},{"issue":"1","key":"772_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s43066-023-00283-7","volume":"13","author":"M Yesmin","year":"2023","unstructured":"Yesmin M, Biswas NK, Alam A. Liver function test (SGPT) abnormality in 319 confirmed COVID-19 cases in Bangladesh. Egypt Liver J. 2023;13(1):48.","journal-title":"Egypt Liver J"},{"key":"772_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.944909","volume":"9","author":"Q Li","year":"2022","unstructured":"Li Q, Liu X, Li L, Hu X, Cui G, Sun R, et al. Comparison of clinical characteristics between SARS-CoV-2 Omicron variant and delta variant infections in China. Front Med. 2022;9:944909.","journal-title":"Front Med"},{"issue":"5","key":"772_CR35","doi-asserted-by":"publisher","first-page":"751","DOI":"10.5603\/CJ.a2022.0056","volume":"29","author":"B Fialek","year":"2022","unstructured":"Fialek B, Pruc M, Smereka J, Jas R, Rahnama-Hezavah M, Denegri A, et al. Diagnostic value of lactate dehydrogenase in COVID-19: a systematic review and meta-analysis. Cardiol J. 2022;29(5):751\u20138.","journal-title":"Cardiol J"},{"issue":"2","key":"772_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2025.105026","volume":"55","author":"J Pehlivan","year":"2025","unstructured":"Pehlivan J, Berge P, Gourdier A-L, Phelippeau M, Danneels P, Mahieu R, et al. Delta and omicron SARS-CoV-2 pneumonia: comparison of clinical and radiological features. Infectious Diseases Now. 2025;55(2):105026.","journal-title":"Infectious Diseases Now"},{"key":"772_CR37","doi-asserted-by":"publisher","unstructured":"W\u00f3jcik K, Masiak A, Jeleniewicz R, Jakuszko K, Brzosko I, Storoniak H, Kur-Zalewska J, Wis\u0142owska M, Madej M, Hawrot-Kawecka A, et al. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA\u2013associated vasculitides. Pol archives Intern Med. 2022;132(3):16187. https:\/\/doi.org\/10.20452\/pamw.16187","DOI":"10.20452\/pamw.16187"},{"issue":"4","key":"772_CR38","first-page":"720","volume":"40","author":"G Biedro\u0144","year":"2022","unstructured":"Biedro\u0144 G, W\u0142udarczyk A, Wawrzycka-Adamczyk K, W\u00f3jcik K, Musia\u0142 J, Bazan-Socha S, et al. Respiratory involvement in antineutrophil cytoplasmic antibody-associated vasculitides: a retrospective study based on POLVAS registry. Clin Exp Rheumatol. 2022;40(4):720\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"772_CR39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.akdh.2024.08.006","volume":"31","author":"A Koirala","year":"2024","unstructured":"Koirala A, Sharma PD, Jhaveri KD, Jain K, Geetha D. Rapidly progressive glomerulonephritis. Advances in Kidney Disease and Health. 2024;31(6):485\u201395.","journal-title":"Advances in Kidney Disease and Health"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00772-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:01:52Z","timestamp":1763136112000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00772-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00772-x","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Hormozgan University of Medical Sciences in accordance with the Declaration of Helsinki (approval code: IR.HUMS.REC.1400.376). Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}